Craneware Share News (CRW)

AIM-quoted Craneware, which provides revenue calculating software to US hospitals, says that its interim profit is set to grow by more than one-third. Revenues are 24% ahead at $16.6m in the six months to December 2010, while EBITDA is likely to be 35% higher at $4.6m. Broker Evolution says that the interims are likely to be at the top of the forecast range and it believes that there could be upward pressure on forecasts. Craneware believes it can continue to prosper in the US healthcare market despite the uncertainties at the moment. Evolution currently forecasts a rise in profit from $7.3m to $9.2m in the year to June 2011. The interim figures will be published on 28 February.